These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 14614562)

  • 1. Abnormal ghrelin secretion in new onset childhood Type 1 diabetes.
    Holdstock C; Ludvigsson J; Karlsson FA
    Diabetologia; 2004 Jan; 47(1):150-1. PubMed ID: 14614562
    [No Abstract]   [Full Text] [Related]  

  • 2. Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age.
    Acerini CL; Cheetham TD; Edge JA; Dunger DB
    Diabetologia; 2000 Jan; 43(1):61-8. PubMed ID: 10663217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin treatment reduces pre-prandial plasma ghrelin concentrations in children with type 1 diabetes.
    Ashraf A; Mick G; Meleth S; Wang X; McCormick K
    Med Sci Monit; 2007 Dec; 13(12):CR533-7. PubMed ID: 18049431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of Lispro insulin with meals improves glycemic control, increases circulating leptin, and suppresses ghrelin, compared with regular/NPH insulin in female patients with type 1 diabetes.
    Griffen SC; Oostema K; Stanhope KL; Graham J; Styne DM; Glaser N; Cummings DE; Connors MH; Havel PJ
    J Clin Endocrinol Metab; 2006 Feb; 91(2):485-91. PubMed ID: 16317063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Scylla and Charybdis of blood glucose control in children with diabetes mellitus.
    Sperling MA
    J Pediatr; 1997 Mar; 130(3):339-41. PubMed ID: 9063403
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoglycemia associated with maprotiline in a patient with type 1 diabetes.
    Isotani H; Kameoka K
    Diabetes Care; 1999 May; 22(5):862-3. PubMed ID: 10332704
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
    Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ
    Regul Pept; 2006 Dec; 137(3):173-8. PubMed ID: 16928403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy.
    Martos-Moreno GA; Barrios V; Soriano-Guillén L; Argente J
    Eur J Endocrinol; 2006 Nov; 155(5):757-61. PubMed ID: 17062893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
    Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
    Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin gene transfer can be a new optional therapy for replacement of pancreas.
    Kuzume M; Yamaguchi M; Matsumoto T; Matsumiya A; Shimura H; Nakano H; Kumada K; Takeda M
    Transplant Proc; 1998 Nov; 30(7):3416. PubMed ID: 9838505
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development.
    Celi F; Bini V; Papi F; Santilli E; Ferretti A; Mencacci M; Berioli MG; De Giorgi G; Falorni A
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):139-45. PubMed ID: 16060906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin increases serum leptin concentrations in children and adolescents with newly diagnosed type I diabetes mellitus with and without ketoacidosis.
    Flück CE; Kuhlmann BV; Mullis PE
    Diabetologia; 1999 Sep; 42(9):1067-70. PubMed ID: 10447517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A failure to communicate.
    Curry A
    Diabetes Forecast; 2014 Jan; 67(1):92-3. PubMed ID: 25868303
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
    Chaillous L; Bouhanick B; Kerlan V; Mathieu E; Lecomte P; Ducluzeau PH; Delamaire M; Sonnet E; Maugendre D; Maréchaud R; Rohmer V; Saï P; Charbonnel B
    Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixtures of soluble insulin with zinc-suspension or protamine insulin have different effect on blood glucose and free insulin levels in insulin dependent diabetes.
    Lunetta M; Di Mauro M; Mughini L
    Diabete Metab; 1988; 14(3):315-6. PubMed ID: 3044867
    [No Abstract]   [Full Text] [Related]  

  • 17. Do we really need continuous glucose monitoring?
    Peters A
    Diabetes Technol Ther; 2009 Jun; 11 Suppl 1():S128-30. PubMed ID: 19469672
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control.
    Rjasanowski I; Michaelis D; Keilacker H; Besch W; Richter KV; Heinke P
    Exp Clin Endocrinol; 1987 Apr; 89(2):216-24. PubMed ID: 3301371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLOuDs Disperse - Top-Notch Glucose Control and Residual C-Peptide Secretion.
    Bolinder J
    N Engl J Med; 2022 Sep; 387(10):937-938. PubMed ID: 36069877
    [No Abstract]   [Full Text] [Related]  

  • 20. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
    Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.